Redeye updates its estimates following Sleep Cycle’s Q2’22 report. We also discuss price optimization, ARPU impact, net intake of subscribers, and competition concerns. We believe the latter explains the depressed share price, despite solid financial performance in the first half of 2022.
LÄS MER